JP2023532046A5 - - Google Patents
Info
- Publication number
- JP2023532046A5 JP2023532046A5 JP2022580315A JP2022580315A JP2023532046A5 JP 2023532046 A5 JP2023532046 A5 JP 2023532046A5 JP 2022580315 A JP2022580315 A JP 2022580315A JP 2022580315 A JP2022580315 A JP 2022580315A JP 2023532046 A5 JP2023532046 A5 JP 2023532046A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063044980P | 2020-06-26 | 2020-06-26 | |
| US63/044,980 | 2020-06-26 | ||
| PCT/US2021/039139 WO2021263134A1 (en) | 2020-06-26 | 2021-06-25 | Recombinant modified fibroblast growth factors and therapeutic uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023532046A JP2023532046A (ja) | 2023-07-26 |
| JP2023532046A5 true JP2023532046A5 (https=) | 2024-07-02 |
| JPWO2021263134A5 JPWO2021263134A5 (https=) | 2024-07-02 |
Family
ID=79281929
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022580315A Pending JP2023532046A (ja) | 2020-06-26 | 2021-06-25 | 組換え修飾線維芽細胞増殖因子およびそれを使用した治療 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20240024421A1 (https=) |
| EP (1) | EP4172351A4 (https=) |
| JP (1) | JP2023532046A (https=) |
| KR (1) | KR20230066318A (https=) |
| CN (1) | CN116710568A (https=) |
| WO (1) | WO2021263134A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4621067A3 (en) | 2017-05-05 | 2025-11-19 | Trefoil Therapeutics, Inc. | Recombinant modified fibroblast growth factors and therapeutic uses thereof |
| TWI865835B (zh) * | 2020-11-16 | 2024-12-11 | 雅祥生技醫藥股份有限公司 | 穩定的酸性纖維母細胞生長因子組合物 |
| US20230022990A1 (en) * | 2021-05-14 | 2023-01-26 | Claris Biotherapeutics, Inc. | Compositions of growth factor for the treatment of eye disease |
| WO2023019218A1 (en) * | 2021-08-12 | 2023-02-16 | Trefoil Therapeutics, Inc. | Modified fibroblast growth factors for treating fibrotic diseases |
| AU2024247068A1 (en) * | 2023-03-28 | 2025-10-16 | Trefoil Therapeutics, Inc. | Recombinant modified fibroblast growth factors and therapeutic uses thereof |
| CN116392441B (zh) * | 2023-04-21 | 2023-11-28 | 上海腾瑞制药股份有限公司 | 一种酸性成纤维细胞生长因子滴眼液制剂 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4022758A (en) * | 1973-06-19 | 1977-05-10 | Ab Kabi | Isolation of coagulation factors I and VIII from biological material |
| US5052558A (en) | 1987-12-23 | 1991-10-01 | Entravision, Inc. | Packaged pharmaceutical product |
| US5033252A (en) | 1987-12-23 | 1991-07-23 | Entravision, Inc. | Method of packaging and sterilizing a pharmaceutical product |
| US5323907A (en) | 1992-06-23 | 1994-06-28 | Multi-Comp, Inc. | Child resistant package assembly for dispensing pharmaceutical medications |
| US20050227929A1 (en) | 2003-11-13 | 2005-10-13 | Masferrer Jaime L | Combination therapy comprising a Cox-2 inhibitor and an antineoplastic agent |
| US7790682B1 (en) | 2003-12-02 | 2010-09-07 | The Florida State University Research Foundation, Inc. | Engineered human acidic fibroblast growth factors and associated methods |
| JP2009534390A (ja) * | 2006-04-21 | 2009-09-24 | アムジェン インコーポレイテッド | 生物医薬品製剤のための緩衝剤 |
| US20080125580A1 (en) * | 2006-07-14 | 2008-05-29 | Genentech, Inc. | Refolding of Recombinant Proteins |
| ES2516694T3 (es) * | 2006-07-21 | 2014-10-31 | Ratiopharm Gmbh | Glicosilación de péptidos a través de secuencias de glicosilación con unión en O |
| US7696171B1 (en) | 2006-11-09 | 2010-04-13 | The Florida State University Research Foundation, Inc. | Mutant polypeptides of fibroblast growth factor 1 |
| US7659379B1 (en) | 2007-05-24 | 2010-02-09 | Florida State University Research Foundation, Inc. | Mutants of human fibroblast growth factor having increased stability and/or mitogenic potency |
| US8461111B2 (en) | 2009-05-20 | 2013-06-11 | Florida State University Research Foundation | Fibroblast growth factor mutants having improved functional half-life and methods of their use |
| US20110224404A1 (en) | 2010-03-11 | 2011-09-15 | Florida State University Research Foundation | Method for development of a peptide building block useful for de novo protein design |
| CA2796459C (en) * | 2010-04-16 | 2016-05-24 | Salk Institute For Biological Studies | Methods for treating metabolic disorders using fgf-1 |
| US9714291B2 (en) * | 2012-10-05 | 2017-07-25 | Kyowa Hakko Kirin Co., Ltd | Heterodimer protein composition |
| EP3419599A4 (en) * | 2016-02-23 | 2019-09-11 | Sesen Bio, Inc. | IL-6 ANTAGONIST FORMULATIONS AND USE THEREOF |
| EP4621067A3 (en) * | 2017-05-05 | 2025-11-19 | Trefoil Therapeutics, Inc. | Recombinant modified fibroblast growth factors and therapeutic uses thereof |
| CN111315886A (zh) * | 2017-06-23 | 2020-06-19 | 珠海亿胜生物制药有限公司 | 重组人碱性成纤维细胞生长因子(rh-bFGF)以及包含rh-bFGF的药物组合物 |
| US11103552B2 (en) * | 2018-05-10 | 2021-08-31 | Regeneron Pharmaceuticals, Inc. | High concentration VEGF receptor fusion protein containing formulations |
-
2021
- 2021-06-25 EP EP21829103.7A patent/EP4172351A4/en active Pending
- 2021-06-25 CN CN202180053250.XA patent/CN116710568A/zh active Pending
- 2021-06-25 KR KR1020237002819A patent/KR20230066318A/ko not_active Withdrawn
- 2021-06-25 JP JP2022580315A patent/JP2023532046A/ja active Pending
- 2021-06-25 WO PCT/US2021/039139 patent/WO2021263134A1/en not_active Ceased
-
2022
- 2022-12-21 US US18/069,585 patent/US20240024421A1/en active Pending